These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30321898)

  • 1. Ensuring Justice in Access to Investigational Neurological Drugs.
    Kearns L; Bateman-House A; Caplan A
    Semin Neurol; 2018 Oct; 38(5):583-588. PubMed ID: 30321898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs.
    Puthumana J; Miller JE; Kim J; Ross JS
    JAMA Netw Open; 2018 Jun; 1(2):e180283. PubMed ID: 30646072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanded access to investigational drugs for treatment use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
    Ochs A
    Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
    [No Abstract]   [Full Text] [Related]  

  • 6. The Food and Drug Administration and pragmatic clinical trials of marketed medical products.
    Anderson ML; Griffin J; Goldkind SF; Zeitler EP; Wing L; Al-Khatib SM; Sherman RE
    Clin Trials; 2015 Oct; 12(5):511-9. PubMed ID: 26374684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting Patient Interests in Implementing the Federal Right to Try Act.
    Lynch HF; Zettler PJ; Sarpatwari A
    JAMA; 2018 Sep; 320(9):869-870. PubMed ID: 30105394
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethical and regulatory challenges in advancing prehospital research: focus on sepsis.
    Polito CC; Sevransky JE; Dickert NW
    Am J Emerg Med; 2016 Mar; 34(3):623-5. PubMed ID: 26851062
    [No Abstract]   [Full Text] [Related]  

  • 10. Informed consent and investigational new drug abuses in the U.S. military.
    Cummings ML
    Account Res; 2002; 9(2):93-103. PubMed ID: 12625353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oversight of Right-to-Try and Expanded Access Requests for Off-Trial Access to Investigational Drugs.
    Chapman CR; Eckman J; Bateman-House AS
    Ethics Hum Res; 2020 Jan; 42(1):2-13. PubMed ID: 31967412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Federal Right to Try Act of 2017-A Wrong Turn for Access to Investigational Drugs and the Path Forward.
    Bateman-House A; Robertson CT
    JAMA Intern Med; 2018 Mar; 178(3):321-322. PubMed ID: 29356821
    [No Abstract]   [Full Text] [Related]  

  • 13. Compassionate use of unauthorized drugs: Legal regulations and ethical challenges.
    Borysowski J; Górski A
    Eur J Intern Med; 2019 Jul; 65():12-16. PubMed ID: 31036436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-patient expanded access: A primer for pharmacists.
    Smith AJF; Redic KA
    Am J Health Syst Pharm; 2022 Nov; 79(23):2118-2127. PubMed ID: 36056791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigational new drug application; exception from informed consent; technical amendment--FDA. Final rule.
    Fed Regist; 1997 Jun; 62(115):32479. PubMed ID: 10169828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Often Are Drugs Made Available Under the Food and Drug Administration's Expanded Access Process Approved?
    McKee AE; Markon AO; Chan-Tack KM; Lurie P
    J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S136-S142. PubMed ID: 28921646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Food and Drug Administration's experimental drug approval system: is it good for your health?
    Myers BE
    Houst Law Rev; 1991 Jan; 28(1):309-36. PubMed ID: 12426696
    [No Abstract]   [Full Text] [Related]  

  • 18. Walking a thin line: distinguishing between research and medical practice during Operation Desert Storm.
    Schuchardt EJ
    Spec Law Dig Health Care Law; 1993 Nov; (177):9-47. PubMed ID: 10130675
    [No Abstract]   [Full Text] [Related]  

  • 19. Minnesota's Right to Try law.
    Hermer LD
    Minn Med; 2016; 99(1):30-2. PubMed ID: 26897894
    [No Abstract]   [Full Text] [Related]  

  • 20. The ethical plausibility of the 'Right To Try' laws.
    Carrieri D; Peccatori FA; Boniolo G
    Crit Rev Oncol Hematol; 2018 Feb; 122():64-71. PubMed ID: 29458791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.